These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19402664)

  • 1. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
    Gynther M; Ropponen J; Laine K; Leppänen J; Haapakoski P; Peura L; Järvinen T; Rautio J
    J Med Chem; 2009 May; 52(10):3348-53. PubMed ID: 19402664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large neutral amino acid transporter enables brain drug delivery via prodrugs.
    Gynther M; Laine K; Ropponen J; Leppänen J; Mannila A; Nevalainen T; Savolainen J; Järvinen T; Rautio J
    J Med Chem; 2008 Feb; 51(4):932-6. PubMed ID: 18217702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain uptake of ketoprofen-lysine prodrug in rats.
    Gynther M; Jalkanen A; Lehtonen M; Forsberg M; Laine K; Ropponen J; Leppänen J; Knuuti J; Rautio J
    Int J Pharm; 2010 Oct; 399(1-2):121-8. PubMed ID: 20727958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
    Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease.
    Deguchi Y; Hayashi H; Fujii S; Naito T; Yokoyama Y; Yamada S; Kimura R
    J Drug Target; 2000; 8(6):371-81. PubMed ID: 11328663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-type amino acid transporter 1 utilizing prodrugs: How to achieve effective brain delivery and low systemic exposure of drugs.
    Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM
    J Control Release; 2017 Sep; 261():93-104. PubMed ID: 28662899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets.
    Puris E; Gynther M; de Lange ECM; Auriola S; Hammarlund-Udenaes M; Huttunen KM; Loryan I
    Mol Pharm; 2019 Jul; 16(7):3261-3274. PubMed ID: 31180686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate.
    Dalpiaz A; Filosa R; de Caprariis P; Conte G; Bortolotti F; Biondi C; Scatturin A; Prasad PD; Pavan B
    Int J Pharm; 2007 May; 336(1):133-9. PubMed ID: 17184941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).
    Ylikangas H; Malmioja K; Peura L; Gynther M; Nwachukwu EO; Leppänen J; Laine K; Rautio J; Lahtela-Kakkonen M; Huttunen KM; Poso A
    ChemMedChem; 2014 Dec; 9(12):2699-707. PubMed ID: 25205473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs.
    Mori S; Ohtsuki S; Takanaga H; Kikkawa T; Kang YS; Terasaki T
    J Neurochem; 2004 Aug; 90(4):931-41. PubMed ID: 15287899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation.
    Park S; Sinko PJ
    Drug Metab Dispos; 2005 Oct; 33(10):1547-54. PubMed ID: 16033951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery.
    Puris E; Gynther M; Huttunen J; Auriola S; Huttunen KM
    Eur J Pharm Sci; 2019 Mar; 129():99-109. PubMed ID: 30625368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese distribution across the blood-brain barrier III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake.
    Crossgrove JS; Yokel RA
    Neurotoxicology; 2004 Mar; 25(3):451-60. PubMed ID: 15019308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2.
    Li JY; Boado RJ; Pardridge WM
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):929-36. PubMed ID: 11487728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
    Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).
    Terasaki T; Pardridge WM
    J Drug Target; 2000; 8(6):353-5. PubMed ID: 11328661
    [No Abstract]   [Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs.
    More SS; Vince R
    J Med Chem; 2008 Aug; 51(15):4581-8. PubMed ID: 18651729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
    Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
    Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
    Tachikawa M; Kasai Y; Yokoyama R; Fujinawa J; Ganapathy V; Terasaki T; Hosoya K
    J Neurochem; 2009 Oct; 111(2):499-509. PubMed ID: 19682207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
    Bhattacharya I; Boje KM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):92-8. PubMed ID: 15173314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.